Rheumatoid arthritis is the most common autoimmune arthritis in adult population. This disease is characterized by joint damage and systemic involvement that lead to general physical and mental impairment with consequent worsening of quality of life. Rheumatoid arthritis is also associated with a large economic burden to healthcare systems. The evidence from the literature indicates that, despite available treatments, several unmet needs still interfere with rheumatoid arthritis management. Based on this evidence, some of the unmet medical needs currently present in the management of the rheumatoid arthritis were identified and a Delphi questionnaire was submitted to 60 Italian Rheumatologists. The aim of this Delphi was to achieve a broad ...
OBJECTIVES: Despite availability of efficacious treatments, unmet needs still exist, preventing opti...
RHEUMATOID ARTHRITIS (RA) is the most common inflammatory rheumatic disease, with a prevalence of ab...
Background Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such...
Rheumatoid arthritis is the most common autoimmune arthritis in adult population. This disease is ch...
Rheumatoid arthritis is the most common autoimmune arthritis in adult population. This disease is ch...
Copyright © 2013 Janet Pope, Bernard Combe. This is an open access article distributed under the Cre...
Despite significant improvement in the management of rheumatoid arthritis (RA), a substantial propor...
Rheumatoid arthritis used to be a disabling disease with very poor outcome and overall quality of li...
Rheumatoid arthritis (RA) is a multifactorial autoimmune disease of unknown etiology, primarily affe...
To develop a comprehensive listing of the greatest unmet scientific and clinical needs in rheumatolo...
International audienceObjectives: Despite availability of efficacious treatments, unmet needs still ...
Rheumatoid arthritis (RA) is a chronic, progressive and degenerative illness, which affects about 0....
Increased effectiveness of pharmacological treatments in early RA has led many to believe that diffi...
The goals for the management of established rheumatoid arthritis (RA) differ slightly from the goals...
OBJECTIVES: To detail the greatest areas of unmet scientific and clinical needs in rheumatology. MET...
OBJECTIVES: Despite availability of efficacious treatments, unmet needs still exist, preventing opti...
RHEUMATOID ARTHRITIS (RA) is the most common inflammatory rheumatic disease, with a prevalence of ab...
Background Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such...
Rheumatoid arthritis is the most common autoimmune arthritis in adult population. This disease is ch...
Rheumatoid arthritis is the most common autoimmune arthritis in adult population. This disease is ch...
Copyright © 2013 Janet Pope, Bernard Combe. This is an open access article distributed under the Cre...
Despite significant improvement in the management of rheumatoid arthritis (RA), a substantial propor...
Rheumatoid arthritis used to be a disabling disease with very poor outcome and overall quality of li...
Rheumatoid arthritis (RA) is a multifactorial autoimmune disease of unknown etiology, primarily affe...
To develop a comprehensive listing of the greatest unmet scientific and clinical needs in rheumatolo...
International audienceObjectives: Despite availability of efficacious treatments, unmet needs still ...
Rheumatoid arthritis (RA) is a chronic, progressive and degenerative illness, which affects about 0....
Increased effectiveness of pharmacological treatments in early RA has led many to believe that diffi...
The goals for the management of established rheumatoid arthritis (RA) differ slightly from the goals...
OBJECTIVES: To detail the greatest areas of unmet scientific and clinical needs in rheumatology. MET...
OBJECTIVES: Despite availability of efficacious treatments, unmet needs still exist, preventing opti...
RHEUMATOID ARTHRITIS (RA) is the most common inflammatory rheumatic disease, with a prevalence of ab...
Background Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such...